How to Care for Implanted Ports
Journal Title: Iranian Journal of Blood and Cancer - Year 2013, Vol 5, Issue 3
Abstract
Implantable ports are used for intravenous infusion therapy and play an important role in management of oncology patients. These ports are best suited for patients requiring long-term therapy (>4 weeks). Implanted ports provide reliable venous access protect peripheral access increase patients’ comfort through reducing repeated and difficult vein punctures allow for safe and comfortable administration of concentrated solutions, vesicants or irritants with minimal risk of extravasations and chemical phlebitis help patients avoid anxiety related to repeated vein puncture and provide a better quality of life. Implanted port systems and their needles are from a variety of types and materials. They are inserted with a surgical technique through an incision into subcutaneous tissue commonly in the upper chest wall. Implanted ports need some care including: flushing, locking, dressing, change of needle and minimizing the risk of contamination by scrubbing the access port with an appropriate antiseptic. The aim of this review is to provide evidence on managing port systems in order to improve practice, boost patient outcomes and reduce complications and health care costs. Keyword: Implanted port, care, chemotherapy.
Authors and Affiliations
Mohammad Kazem Nourbakhsh, Afsaneh Nekoee, Shahnaz Nemati, Mahin Gheibizadeh
Keywords
Related Articles
- EP ID EP365841
- DOI -
- Views 81
- Downloads 0
Density of Platelet GPIIb-IIIa and Bleeding Severity in Iranian Patients with Glanzmann’s Thrombasthenia
Background: Glanzmann’s Thrombasthenia (GT) is a rare autosomal, recessive, bleeding syndrome. The main aim of this study was to investigate the relationship between symptoms, bleeding severity, and gender and subtypes o...
Neonatal Screening for Sickle Cell Disease in South West Iran: a Pilot Study
Background: Children affected with sickle cell disease (SCD) are at increased risk for severe morbidity and mortality, especially during the first 3-5 years of life. It is suggested that early treatment can improve the c...
Serum Antioxidant Levels in Children with Beta-Thalassemia Major
Background: Thalassemia represents a serious health problem in Iran because of its heterogeneous frequency and the existing endogamy system. It is an inherited blood disease characterized by the under production of norm...
Comparison of the Quality of Life among Patients with Idiopathic Thrombocytopenic Purpura and Healthy People in Isfahan, Iran
Background: Quality of life has been used as an important tool to understand illnesses impact in recent decades. Idiopathic thrombocytopenic purpura is a chronic disease which affects the individuals’ quality of life. Th...
Health-Related Quality of Life in β Thalassemia Major Children in North of Iran
Background: Advances in treatment of thalassemia major have improved the life expectancy of the patients and therefore their quality of life as other chronic diseases. This study was conducted to assess health- related q...